Expand ALGS Menu

ALGS Stock Summary and Trading Ideas (Aligos Therapeutics | NASDAQ:ALGS)

Charts for Today's Stock Price and Implied Volatility in Aligos Therapeutics

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for ALGS by Theoretical Edge and Win Rates


Trading Statistics

Key Ratios

Aligos Therapeutics (ALGS) Frequently Asked Questions

What does Aligos Therapeutics do?

Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

What symbol and exchange does Aligos Therapeutics stock trade?

Aligos Therapeutics trades on the NASDAQ stock market under the symbol ALGS.

What is Aligos Therapeutics stock price doing today?

As of June 18, 2024, ALGS stock price declined to $0.45 with 51,630 million shares trading.

What is Aligos Therapeutics's Beta?

ALGS has a beta of 2.51, meaning it tends to be more sensitive to market movements. ALGS has a correlation of 0.14 to the broad based SPY ETF.

How much is Aligos Therapeutics worth?

ALGS has a market cap of $35.15 million. This is considered a Sub-Micro Cap stock.

What is the highest and lowest price Aligos Therapeutics traded in the last 3 year period?

In the last 3 years, ALGS stock traded as high as $28.39 and as low as $.44.

What are the top ETFs holding Aligos Therapeutics?

The top ETF exchange traded funds that ALGS belongs to (by Net Assets): VTI, VXF, IWC.

Is Aligos Therapeutics (ALGS) a good investment?

ALGS has underperformed the market in the last year with a price return of -59.1% while the SPY ETF gained +25.8%. ALGS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -51.2% and -27.0%, respectively, while the SPY returned +7.4% and +3.8%, respectively.

What is the support and resistance for Aligos Therapeutics (ALGS) stock price?

ALGS support price is $.44 and resistance is $.50 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALGS stock will trade within this expected range on the day.